Multiparticulate bisoprolol formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6733789
SERIAL NO

09488103

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A multiparticulate bisoprolol formulation for once-daily oral administration, each particle of which comprises a core of bisoprolol or a pharmaceutically acceptable salt thereof surrounded by a polymeric coating, the polymeric coating being effective to achieve an initial lag of bisoprolol release in vivo of at least 4-6 hours following administration and thereafter maintaining therapeutic concentrations of bisoprolol for the remainder of the twenty-four hour period. The formulation can be used for night-time dosing so as to minimize the likelihood of acute cardiovascular occurrences in the well-documented high risk period in the morning.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CIRC PHARMA RESEARCH AND DEVELOPMENT LIMITED45 FITZWILLIAM SQUARE DUBLIN 2

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fanning, Niall M Rush, IE 2 32
Kelly, Catherine Mary Athlone, IE 2 32
Stark, Paul Athlone, IE 46 1814

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation